A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer
2009 ◽
Vol 113
(2)
◽
pp. 210-215
◽
Kathleen M. Schmeler
◽
Saroj Vadhan-Raj
◽
Pedro T. Ramirez
◽
Sachin M. Apte
◽
Lorenzo Cohen
◽
...
2011 ◽
Vol 2011
◽
pp. 74-75
2011 ◽
Vol 2011
◽
pp. 154-155
2011 ◽
Vol 120
(3)
◽
pp. 454-458
◽
Thomas J. Herzog
◽
Michael W. Sill
◽
Joan L. Walker
◽
David O'Malley
◽
Mark Shahin
◽
...
2017 ◽
Vol 28
◽
pp. v352-v353
K.N. Moore
◽
K.A. Cadoo
◽
S. Chambers
◽
S. Ghamande
◽
G. Konecny
◽
...
2012 ◽
Vol 126
(3)
◽
pp. 369-374
◽
Marcela G. del Carmen
◽
John Micha
◽
Laurie Small
◽
Daron G. Street
◽
Anil Londhe
◽
...
L. Xia
◽
Q. Zhou
◽
Y. Zhang
◽
Y. Gao
◽
W. Hu
◽
...
2015 ◽
Vol 33
(15_suppl)
◽
pp. 5580-5580
John Ben Liao
◽
Ron E. Swensen
◽
Jessica Reichow
◽
Kelsie J Ovenell
◽
Jennifer Childs
◽
...
2016 ◽
Vol 141
◽
pp. 207
◽
U.A. Matulonis
◽
M. Sill
◽
P.H. Thaker
◽
J.W. Carlson
◽
C.J. Darus
◽
...
A. Van Arsdale
◽
M.H. Einstein
◽
M.A. Brewer
◽
P.F. Timmins
◽
J.D. Wright
◽
...
Linda Duska
◽
David M. O'Malley
◽
Carolyn Krasner
◽
Russell J. Schilder
◽
Cara Mathews
◽
...
Close
Export Citation Format
Close
Share Document
Close